There are seniors across New York City who will argue that they didn’t need a study to tell them that older unvaccinated adults were more likely to be hospitalized or die from COVID-19.

Research has since confirmed those findings but before there was a vaccine, some local seniors said they saw that trend with their own eyes.

“I was fortunate but sure I know people who got sick. I know people who died from COVID,” said Richard Allman, a Manhattan senior.

That personal experience is why Allman said that he will sign up as soon as possible to get a third dose of Pfizer’s COVID-19 vaccine booster shot.

On Friday, an FDA advisory panel voted to recommend a third dose of the Pfizer vaccine for those 65 and older.

“I will personally choose to take the booster. I think the science has guided is well up to this point,” said Allman.

That science is why several health professionals that Friday’s FDA panel decision was something they expected.

Pfizer had also sought to get their booster shot approved for everyone 16 and over but experts said they don’t think a third shot is needed for the general population at this point.

“If it’s not really necessary than you don’t want to do it because it’s a really large scale effort, it’s a lot vaccines that would be used,” said Donna Farber, Ph.D., a professor at Columbia University’s department of microbiology and immunology.

“I really don’t think is necessary and we need to keep this in context of really wanting to do the safest thing for the entire planet and getting first doses rolled out in the rest of the world is much higher of a priority,” said Eric Cioe-Peña, MD, director of Global Health at Northwell Heath.

The panel’s decision is not final and still needs a full approval before the plan can be implemented.

That decision is expected to take place in the coming days.